NCT06785376 (P3) is a NA clinical trial of DIY (Do It Yourself) in HIV Testing, sponsored by Columbia University.

Who is sponsoring NCT06785376?

NCT06785376 is sponsored by Columbia University.

What drugs are being tested in NCT06785376?

Interventions in NCT06785376: DIY (Do It Yourself), TRUST, SOC.

What condition does NCT06785376 study?

NCT06785376 studies HIV Testing, PrEP Uptake.

Is NCT06785376 still recruiting?

NCT06785376 is currently recruiting now. Last updated 21 January 2025.

Last reviewed 2025-01-21 · How we verify

NCT06785376: P3

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

P3 Trial: Estimating the Impact of a Multilevel, Multicomponent Intervention to Increase Uptake of HIV Testing and Biomedical HIV Prevention Among African-American/Black Gay, Bisexual, and Same-gender Loving Men

Recruiting now NA Last updated 21 January 2025

What this trial tests

NA trial testing DIY (Do It Yourself) in HIV Testing in 480 participants. Currently enrolling.

Timeline

19 December 2024

Primary endpoint
28 February 2028

28 February 2028

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	single
Primary purpose	prevention
Enrollment	480
Start date	19 December 2024
Primary completion	28 February 2028
Estimated completion	28 February 2028
Sites	1 location across United States

Drugs / interventions tested

DIY (Do It Yourself)
TRUST
SOC

Conditions studied

HIV Testing — all drugs for HIV Testing →
PrEP Uptake — all drugs for PrEP Uptake →

Sponsor

Columbia University

Who can join

Adults 18 to 65, male only, with HIV Testing or PrEP Uptake. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The major goal of this study is to evaluate a multi-component, multilevel HIV prevention intervention that targets theoretically-informed and empirically-identified barriers to and facilitators of both HIV testing and PEP/PrEP uptake by combining existing evidence-based and novel evidence-informed components and integrating them into a community-based organization's (CBO) standard of care (SOC) PEP/PrEP navigation program. The evaluation will apply use a 2x2 factorial design to randomize and follow for 18 months 480 PrEP-eligible Black MSM (aged 18-65) living in the NYC area to one of four combinations of interventions. The impact of the social/media campaign, delivered to both geographic (print media) and Black MSM communities (social media) and launched midway through recruitment, will be assessed through assessment of timing and length of exposure as covariates in analysis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Designing Pleasure-Centered, Culturally Relevant PrEP Messaging for Black Gay, Bisexual, Queer, Same-Gender-Loving, and Other Men Who have Sex with Men (SGL/MSM) in New York City.
Bond KT, Williams PM, Paige M, Lam I, et al · · 2026 · PMID 41995922 · DOI 10.1007/s10461-026-05077-7

Verify or expand the search:

Other recruiting trials for HIV Testing

Currently open trials in the same condition.

NCT07074899 — Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru · NA · active not recruiting
NCT05384145 — Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Su · NA · recruiting

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06785376 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 21 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06785376.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing